114 related articles for article (PubMed ID: 36591915)
21. A Nomogram Combining Neutrophil-to-Lymphocyte Ratio and D-Dimer Predicts Chemosensitivity of Oxaliplatin-Based First-Line Chemotherapy in Patients with Unresectable Advanced Gastric Cancer.
Shen H; Wu S; Su R; Chen Y; He Y
Technol Cancer Res Treat; 2022; 21():15330338221112741. PubMed ID: 35880288
[No Abstract] [Full Text] [Related]
22. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
23. Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.
Park JH; Yeo JH; Kim YS; Park I; Ahn HK; Shin DB; Lee WK; Yang JY; Kim HS; Sym SJ
Am J Clin Oncol; 2021 Jun; 44(6):232-238. PubMed ID: 33710139
[TBL] [Abstract][Full Text] [Related]
24. Impact of geriatric nutritional risk index on outcomes after gastrectomy in elderly patients with gastric cancer: a retrospective multicenter study in Japan.
Matsunaga T; Saito H; Osaki T; Takahashi S; Iwamoto A; Fukuda K; Taniguchi K; Kuroda H; Takeuchi T; Sugamura K; Sumi K; Katano K; Shishido Y; Miyatani K; Fujiwara Y
BMC Cancer; 2022 May; 22(1):540. PubMed ID: 35549906
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
[TBL] [Abstract][Full Text] [Related]
26. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
[TBL] [Abstract][Full Text] [Related]
27. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y
BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
Kadowaki S; Komori A; Narita Y; Nitta S; Yamaguchi K; Kondo C; Taniguchi H; Takahari D; Ura T; Ando M; Muro K
Int J Clin Oncol; 2014 Aug; 19(4):656-61. PubMed ID: 23999902
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Langenbecks Arch Surg; 2022 Mar; 407(2):609-621. PubMed ID: 34652563
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer.
Sachlova M; Majek O; Tucek S
Nutr Cancer; 2014; 66(8):1362-70. PubMed ID: 25356861
[TBL] [Abstract][Full Text] [Related]
33. Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resection.
Shang-Guan XC; Chen QY; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH
Surg Oncol; 2018 Mar; 27(1):54-60. PubMed ID: 29549904
[TBL] [Abstract][Full Text] [Related]
34. Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.
Hwang GY; Baek DW; Cho HJ; Lee SJ; Chae YS; Kang BW; Lee IH; Kim JG; Seo AN; Bae HI; Park KB; Park JY; Kwon OK; Lee SS; Chung HY
Anticancer Res; 2018 May; 38(5):3151-3156. PubMed ID: 29715156
[TBL] [Abstract][Full Text] [Related]
35. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients.
Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2022 Nov; 52(11):1560-1567. PubMed ID: 35322296
[TBL] [Abstract][Full Text] [Related]
36. Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding.
Yuan SQ; Nie RC; Chen YM; Qiu HB; Li XP; Chen XJ; Xu LP; Yang LF; Sun XW; Li YF; Zhou ZW; Chen S; Chen YB
Oncol Lett; 2018 Apr; 15(4):4193-4200. PubMed ID: 29541185
[TBL] [Abstract][Full Text] [Related]
37. Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
Parisi A; Cortellini A; Roberto M; Venditti O; Santini D; Dell'Aquila E; Stellato M; Marchetti P; Occhipinti MA; Zoratto F; Mazzuca F; Tinari N; De Tursi M; Iezzi L; Natoli C; Ratti M; Pizzo C; Ghidini M; Porzio G; Ficorella C; Cannita K
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2365-2373. PubMed ID: 31280347
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of the Pre-Treatment Prognostic Nutritional Index for Patients with Unresectable Locally-Advanced and Advanced Stage Upper Gastrointestinal Tract Cancer.
Chantharakhit C; Sujaritvanichpong N; Chantharakhit C
Int J Gen Med; 2022; 15():6681-6689. PubMed ID: 36016983
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
